Hansa Biopharma

News

X-ray of kidneys concept, medical imaging

Australia first for Hansa’s Idefirix in commercial kidney tr...

Hansa has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix.

News

Hansa closes on FDA verdict for transplant drug imlifidase

The FDA has started reviewing Hansa's imlifidase for highly sensitised adults needing a kidney transplant, but not in the requested rapid timeframe.

News

3D Illustration Concept of Human Urinary System Kidneys Anatomy

Hansa gets NICE okay for Idefirix in kidney transplant patie...

Sweden's Hansa Biopharma has claimed a positive opinion from NICE for Idefirix, which becomes the first drug cleared for NHS use in a group of kidney transplant patients for whom finding a

Australia first for Hansa’s Idefirix in commercial kidney tr...

Hansa closes on FDA verdict for transplant drug imlifidase

Hansa gets NICE okay for Idefirix in kidney transplant patie...

Getting predictive technologies to patients, with Concr

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks